We are live on
!
Find out more
Westfield Capital Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
49.45%
This Fund
S&P 500
This Quarter
Est. Return
+7.07%
1 Year Est. Return
+49.45%
3 Year Est. Return
+148.08%
5 Year Est. Return
+180.9%
10 Year Est. Return
+972.24%
AUM
$17.4B
AUM Growth
+$359M
(+2.1%)
Cap. Flow
-$480M
Cap. Flow
% of AUM
-2.77%
Top 10 Holdings %
Top 10 Hldgs %
19.12%
Holding
357
New
45
Increased
93
Reduced
141
Closed
56
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Mastercard
MA
|
+$141M |
| 2 |
DFS
Discover Financial Services
DFS
|
+$129M |
| 3 |
Biogen
BIIB
|
+$126M |
| 4 |
United Therapeutics
UTHR
|
+$124M |
| 5 |
Whirlpool
WHR
|
+$106M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CBST
CUBIST PHARMACEUTICALS INC
CBST
|
+$274M |
| 2 |
ENDP
Endo International plc
ENDP
|
+$207M |
| 3 |
SHPG
Shire pic
SHPG
|
+$206M |
| 4 |
MWIV
MWI VETERINARY SUPPLY, INC.
MWIV
|
+$137M |
| 5 |
JPMorgan Chase
JPM
|
+$132M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.8% |
| 2 | Technology | 14.71% |
| 3 | Consumer Discretionary | 13.45% |
| 4 | Industrials | 12.27% |
| 5 | Communication Services | 9.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Apple
AAPL
$4.89T
| $561M | 3.23% |
18,046,568
-422,384
| -2% | -$12.8M |
|
2
Jazz Pharmaceuticals
JAZZ
$15.9B
| $403M | 2.32% |
2,332,377
+399,081
| +21% | +$68.5M |
|
|
CELG
3
DELISTED
Celgene Corp
CELG
| $395M | 2.27% |
3,423,071
-69,246
| -2% | -$8.27M |
|
4
Alphabet (Google) Class C
GOOG
$3.9T
| $370M | 2.13% |
13,468,597
+99,874
| +0.7% | +$2.68M |
|
5
Teva Pharmaceuticals
TEVA
$35.9B
| $348M | 2.01% |
5,590,871
+932,152
| +20% | +$54.2M |
|
|
AGN
6
DELISTED
Allergan plc
AGN
| $309M | 1.78% |
1,038,182
-21,613
| -2% | -$6.16M |
|
7
AbbVie
ABBV
$458B
| $247M | 1.42% |
4,220,509
+923,695
| +28% | +$55.8M |
|
8
Comcast
CMCSA
$79.1B
| $241M | 1.39% |
8,536,452
-134,994
| -2% | -$3.88M |
|
9
Meta Platforms (Facebook)
META
$1.51T
| $222M | 1.28% |
2,696,497
-56,861
| -2% | -$4.45M |
|
10
Cooper Companies
COO
$13.7B
| $221M | 1.28% |
4,726,348
-386,276
| -8% | -$16.3M |
|
11
Visa
V
$677B
| $201M | 1.16% |
3,073,769
-63,979
| -2% | -$4.23M |
|
12
Salesforce
CRM
$134B
| $195M | 1.12% |
2,911,914
-61,509
| -2% | -$3.82M |
|
13
Microsoft
MSFT
$2.84T
| $192M | 1.11% |
4,718,194
-448,572
| -9% | -$19.5M |
|
14
Booking.com
BKNG
$138B
| $187M | 1.08% |
4,007,350
-72,100
| -2% | -$3.23M |
|
15
Walt Disney
DIS
$165B
| $186M | 1.07% |
1,772,843
-35,704
| -2% | -$3.6M |
|
|
ANDV
16
DELISTED
Andeavor
ANDV
| $186M | 1.07% |
2,036,626
-418,015
| -17% | -$35.1M |
|
17
United Airlines
UAL
$38.4B
| $185M | 1.07% |
2,758,116
+230,546
| +9% | +$15.6M |
|
18
Constellation Brands
STZ
$22.2B
| $171M | 0.99% |
1,474,286
+60,486
| +4% | +$6.81M |
|
19
Home Depot
HD
$332B
| $167M | 0.96% |
1,469,611
+326,278
| +29% | +$36M |
|
20
Aptiv
APTV
$12B
| $158M | 0.91% |
1,976,179
-46,303
| -2% | -$3.48M |
|
21
Valero Energy
VLO
$89.8B
| $157M | 0.9% |
2,462,287
-344,273
| -12% | -$19.2M |
|
|
MON
22
DELISTED
Monsanto Co
MON
| $156M | 0.9% |
1,387,991
-21,896
| -2% | -$2.6M |
|
23
Cardinal Health
CAH
$53.4B
| $153M | 0.88% |
1,696,399
-17,684
| -1% | -$1.52M |
|
|
TFCFA
24
DELISTED
Twenty-First Century Fox, Inc. Class A
TFCFA
| $148M | 0.85% |
4,378,776
-48,729
| -1% | -$1.69M |
|
|
25
Whirlpool
WHR
$2.42B
| $147M | 0.85% |
728,847
+520,757
| +250% | +$106M |
|
Similar funds
OAG
JG
CHP
SAM
Westfield Capital Management's Q1 2015 Portfolio in Review
As of Q1 2015, Westfield Capital Management held 357 positions worth $17.4B, up 2.1% from $17B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Westfield Capital Management's Q1 2015 filing shows 45 new, 93 increased, 141 reduced and 56 closed positions. Its largest new stake was Mastercard: 1,619,899 shares worth $140M. The largest sale was CUBIST PHARMACEUTICALS INC, an estimated $274M.
By sector, the portfolio is most concentrated in Healthcare at 24% of assets, up from 21% a quarter earlier, followed by Technology and Consumer Discretionary.
- Westfield Capital Management's largest Q1 2015 buy was Mastercard: 1,619,899 shares worth $140M.
- Westfield Capital Management added most to Biogen in Q1 2015, an estimated $126M increase.
- Westfield Capital Management's biggest Q1 2015 reduction was Shire pic, cutting an estimated $206M.
- Westfield Capital Management fully exited CUBIST PHARMACEUTICALS INC in Q1 2015, selling an estimated $274M.
- Westfield Capital Management's ten largest holdings make up 19% of its $17.4B portfolio in Q1 2015.
- Westfield Capital Management opened 45 new positions and closed 56 in Q1 2015.
- Westfield Capital Management's portfolio value rose 2.1% quarter-over-quarter to $17.4B.
Based on Westfield Capital Management's 13F filing for Q1 2015, filed 13 May 2015.